首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II
【24h】

Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II

机译:感应化疗(IC)随后是放疗(RT)与甲磺酸/后癌症和室温下的RT可转移只能通过喉喉射精术最终结果进行可转让的喉头植物保存试验DELOS-II

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: The German multicenter randomized phase II larynx organ preservation (LOP) trial DeLOS-II was carried out to prove the hypothesis that cetuximab (E) added to induction chemotherapy (IC) and radiotherapy improves laryngectomy-free survival (LFS; survival with preserved larynx) in locally advanced laryngeal/hypopharyngeal cancer (LHSCC).
机译:背景:德国多中心随机阶段II喉风器官保存(LOP)试验DELOS-II进行了证明,以证明加入诱导化疗(IC)和放射治疗的规定,提高了无喉切除存活(LFS;保存的生存 喉喉部)在局部晚期喉/下白癌(LHSCC)中。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号